Pioneering Patient-led Antibody Therapeutics Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies. Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease. Antibody Therapies, Immunology, and Neuro-dengeneration

83 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the clinically-tested lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit 9dbio.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture

182 similar entities Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

Developing first-in-class CD31xITAM bispecific antibodies for targeted immune modulation Tridek-One Therapeutics pioneers a platform of bispecific antibodies that agonize the CD31 ITIM inhibitory receptor to modulate cell-specific ITAM receptor activation for the treatment of a broad range of inflammatory and autoimmune diseases. The company’s lead program is a first-in-class CD31×GPVI bispecific antibody being developed for the treatment of thromboinflammatory diseases. This novel approach provides both antithrombotic and anti-inflammatory efficacy while minimizing bleeding risk, thereby addressing major critical medical unmet needs in the field. Our company is financed by leading European investors and led by an experienced management team. Santé, Healthcare, …

203 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Allogeneic Cell Therapy Platform that Leverages Natural Platelet Biology PlateletBio is an allogeneic cell therapy company focused on platelet biology. We are pioneers, discovering a new category in therapeutics. Our approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, we’re developing a cell therapy empowered to tackle previously unmet medical challenges. biotechnology, platelets, and drug discovery

459 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Bioceltix is changing the veterinary therapy standards. We develop innovative biopharmaceuticals based on stem cells. Bioceltix is a Wrocław-based and internationally oriented biotechnological company developing innovative, both stem cells and secretome based products, for companion animals. Our flagship technology for manufacturing biopharmaceuticals for veterinary use utilizes the therapeutic potential of allogeneic stem cells (one donor – many recipients). Owning a GMP production facility, we provide single technology for several species, diseases, and routes of administration. Our cutting-edge approach will allow the product to be batch-produced and ready for off-the-shelf sale. The veterinary medicines, based on the immunomodulatory mechanism of action …

231 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.

86 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Valora Therapeutics is a privately held biotech, co-founded with Carolyn Bertozzi, developing multispecific antibodies and T cell engagers that break the glyco-immune checkpoint. Our proprietary AbLecTM and T-LecTM platforms combine precise tumor targeting with localized glyco-immune checkpoint disruption to generate therapeutics with superior anticancer activity without the requirement for delivering toxic payloads. Valora's discovery engine was built on a $30M Seed Round led by Avalon BioVentures.

185 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Antibody Targeted Biologics atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.

100 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The Precision Vaccines Company Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity. Drug development, Cellular immunity, and Platform technology

260 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.” Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success. Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients. Biotechnology, Biotherapeutics, Cell …

201 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

BioCopy is a Swiss-German biotech company with headquarters in Basel and a state-of-the-art R&D facility in Emmendingen, Germany. The company focuses on drastically accelerating the development of safe and effective next-generation cancer drugs to improve the chance of a cure significantly. BioCopy combines artificial intelligence with its automated end-to-end engineering platform to create biotherapeutics with unrivalled efficacy and safety that are transforming the R&D process in today's pharmaceutical industry. The BioCopy platform generates data sets of high quality and quantity currently unmatched in the industry that are essential to leverage the potential of AI. This synergy reduces the research and …

402 similar entities Type: Startup Activities: deeptech Technologies: A.I. Synthetic Biology

Developing Breakthrough Cancer Immunotherapies Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile. Cancer Immunotherapies, Phosphatases, Immuno-Oncology, Checkpoint inhibitors, CAR-T, and Solid tumours and Lymphomas

344 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Memo Therapeutics AG, an Ipsen company, is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections.

215 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

512 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

MImAbs is an innovative start-up specialized in immunotherapy. Our goal is to develop monoclonal antibodies in cancer and inflammatory diseases for third parties (academics, pharmacuetical companies, biotechnologies, etc.) Anticorps monoclonaux, Immuno-pharmacologie, Génération et bioproduction d'anticorps, and Génération d'immunoconjugués

227 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

359 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Global Leader in Recombinant Technology for the Life Sciences Sino Biological is a global leader in recombinant protein and antibody production, gene synthesis, and CRO services for life sciences research and drug development. Its facilities include the Center for Bioprocessing (C4B) in Houston, Texas, which specializes in mammalian cell-based protein and antibody production, and SignalChem Biotech (SCB) in Vancouver, Canada, focusing on kinase-related reagents, stable cell line development, and therapeutic discovery. Sino Biological ensures innovative, high-quality solutions for global academic and industrial clients. Recombinant Protein , Elite Antibody , ELISA kits, Gene/cDNA, CRO Service, Biotechnology tools and solutions, ProVir Viral …

155 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and …

146 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerating antibody discovery with AI bioinformatics solutions for the pharma industry NaturalAntibody develops bioinformatics solutions to facilitate the process of engineering antibody-based therapeutics. The company collects, integrates, and repurposes antibody data points across public and proprietary repositories to learn about antibody structure, function, and diversity. Its solutions support researchers in making the process of designing therapeutic antibodies and drug discovery faster and safer.

62 similar entities Type: Startup Activities: deeptech it services biotech Technologies: A.I. Synthetic Biology

Biotech company specializing in discovery, engineering and manufacturing of monoclonal antibodies Immune Biosolutions is a clinical-stage biotechnology company specializing in the discovery and engineering of avian and human antibodies for therapeutic applications. Utilizing cutting-edge technologies, we develop custom immunotherapeutic agents. Our discovery platform efficiently targets complex proteins and generate powerful, specific, and innovative antibodies. Additionally, our antibody production capability allows us to advance our own discovery programs in cancer and autoimmune diseases into the early phases of clinical development. Anticorps, Custom antibody development, Antibody, Développement sur mesure de génération d'anticorps, IgY, Chicken, Poulet, ELISA, Therapeutic Antibodies, Recombinant Antibodies, Humanized Antibodies, …

104 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Saving lives through affordable and efficient bacterial vaccines Gefjon Pharma has developed a groundbreaking platform technology based on our unique hyper vesiculating outer membrane vesicle (OMV) technology. This combined with our unique extraction method enable high-yield cost-effective production of bio-industrials and therapeutics. Our first product is a revolutionary broad-protective bacterial E. coli vaccine targeting poultry production. We have PoC for both the vaccine and an aerosol application method. With E. coli being the single most important cause of mortality and infections in poultry, we will significantly reduce global consumption of antimicrobials, thereby minimizing the development of antimicrobial resistance (AMR), improve …

89 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Enhancing global health through scientific food ingredients that fortify the gut microbiome We're on a mission to improve global gut health and help combat antimicrobial resistance. Bactolife is a Danish biosolutions company pioneering a new category of food ingredients: HelmTM Binding Proteins that selectively bind and block harmful microbial activity without disturbing the beneficial microbiome. Our binding proteins can be incorporated into foods, beverages, and dietary supplements. Backed by leading investors including Cross Border Impact Ventures, EIFO, Novo Holdings, and Athos, we're working to make HelmTM Binding Proteins a globally accessible solution for better gut health. Join us as we …

47 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible.

114 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Disruptive solutions to produce high-value plant-based ingredients Alkion BioInnovations is a pionnier & leader in plant tissue propagation and bioengineering technologies. We have developed and patented a bioproduction platform to obtain high value ingredients (APIs, complex extracts and recombinant proteins) from plant biomass for pharmaceutical & agri-food markets on global and impactful projects. Through a carbon-neutral approach and using a minimum of resources in optimised bioreactors, our method of production is sustainable, ultra-scalable and cost-efficient. With our European partners, we develop AI robots to build the world's first industrial in-vitro bioproduction platform, that aims to be flexible and versatile. Our …

234 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials

We create all-in-one instruments that make high-throughput single-cell workflows easy thanks to droplet microfluidics At LiveDrop, we develop, build, and sell cutting-edge instruments and methods for high-throughput screening of biological cells and organisms—down to the single-cell level—using microfluidic droplets. Our solutions enable faster, more precise screenings through highly efficient, fully integrated bioassays. LiveDrop’s flagship platform, ModaFlow 4L5C, revolutionises cell screening, drug discovery, and secretome analysis with unparalleled speed and precision. It supports a wide range of applications, including monoclonal antibody discovery, single-cell secretome-based bioassays, high-throughput spheroid manufacturing for drug testing, directed evolution of microbes, and enzyme discovery. We value collaboration …

343 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The glyco design company Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved. Bioproduction and Cell …

84 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined …

95 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

We were made for this 53Biologics is a end-to-end biologics CDMO built to keep progress moving. By combining scientific expertise, integrated in-house capabilities and a collaborative way of working, we enable confident decision-making as biologics programs evolve. We support your biologic from early development to commercialization. With USP and DSP development, GMP manufacturing, quality control and fill-finish connected under one roof, we reduce handoffs, protect continuity and help clients grow without disruption. We were made for this. Biopharmaceuticals , CDMO, pDNA, Recombinant Protein, GMP, Drug Development, Microbial Manufacturing, Cell Banking, and GMP Manufacturing

353 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Reshaping rhBMP-2 Perspectives Relieving suffering and improving quality of life with next-generation orthobiologics. Regenerative Medicine, Biomaterials, Medical devices, Drug delivery, biotechnology, BMP2, Programmed Drug Release, and Instructive Tissue Scaffolds

230 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Re-inventing immunotherapy for allergy Ukko is a biotechnology company dedicated to designing safe immunotherapies to rapidly treat allergies and other immune-mediated conditions. Our proprietary technology platform has the potential to reduce or eliminate potentially dangerous allergic reactions, while inducing a protective immune response. By rethinking how to prevent allergic reactions at the molecular level, we aim to develop a safer, more precise alternative to traditional allergy desensitization methods, starting with individuals at risk for life-threatening allergic reactions to peanut. Allergy, Peanut allergy, Immunotherapy, Immunology, and Biotechnology

59 similar entities Type: Startup Activities: foodtech Technologies: Synthetic Biology

Designing functional antibodies for the most challenging targets. Antiverse is a Welsh techbio company specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to change lives. Headquartered in Cardiff, UK and with offices in Boston, MA, we combine state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. Machine Learning, Antibodies, and Drug discovery

149 similar entities Type: SMB Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Generative A.I. Synthetic Biology

Enabling Proteins for a Better Tomorrow Protevo Bio enables proteins for a better tomorrow. By solving the bottlenecks of conventional production processes, we make bioactive proteins available at large scales and low cost for cost-sensitive industrial applications.

74 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Breaking Biology Free Our patent-pending biotech platform, Phactory, makes designing synthetic proteins 10,000x more effiicent and reduces the material costs by 100x. We are leveraging Phactory to develop the newest classes of protein-based drugs, including binders (nanobodies, bispecific antibodies), toxic proteins, and phage proteins.

165 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work

310 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Protein Sciences (www.proteinsciences.com) is a biotechnology company that specializes in vaccine development and protein production. Our mission is our inspiration: to save lives and improve health by effectively responding to the changing world through the creation of innovative vaccines and biopharmaceuticals. See where Flublok® Influenza vaccine is available at www.flublok.com. We use our proprietary BEVS protein expression technology to produce high quality recombinant proteins quickly, reliably and at low cost. We have developed three main business lines that employ this technology: 1. Proprietary vaccines - we develop and produce the next generation of safer and more effective vaccines 2. GeneXpress® …

133 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming lives with groundbreaking treatments Coultreon Biopharma's mission (formerly Onco3R Therapeutics) is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs. The team is leveraging their knowledge and expertise to bring transformative innovations to patients suffering from auto-immune diseases. In this field, there is an urgent need for more convenient oral drugs that can offer greater efficacy with a better safety profile. Drug Discovery, Drug Development, Immunology, Biotech, and R&D

826 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

a wholly owned subsidiary of Eli Lilly and Company LimmaTech Biologics AG, a wholly owned subsidiary of Eli Lilly and Company, is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. vaccines, research & development, biotechnology, and antimicrobial resistance

419 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine. science+art, biotech, mRNA, IPF, Pulmonary fibrosis, and delivery

561 similar entities Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology

Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, a wholly owned subsidiary of Evotec SE, is an innovative and trusted CDMO for complex biologics, incl. mAbs, bi/multispecifics, and biosimilars. We provide our partners with highly differentiated services for the development and manufacturing of biologics. Our world-leading AI-driven in silico molecular optimization and continuous bioprocessing platforms combined with our revolutionary J.POD® facilities, which represent a paradigm shift within the industry, are helping to reduce the cost of goods and expand global access to affordable, high-quality biotherapeutics in addition to providing a highly agile …

130 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

589 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Delivering local-acting immunotherapies to patients ATMP, Gene Therapy, Drug development, Clinical trials, GMP, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, IBD, Cysticfibrosis, SAVI, colitis, Cystic fibrosis, and Inhalation

646 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing first-in-class solutions for unmet health and personal care needs Results through innovation. We are an innovative biotechnology group with two divisions. Our consumer health arm has commercial products for the personal care market addressing nail, skin, scalp and hair issues. NovaBiotics pharma division has advanced clinical-stage product candidates for medically unmet, life-limiting inflammatory, infectious and respiratory disease. Our highly disruptive solutions to personal care and health needs address significant global markets. biotechnology, biologics, infectious disease, and drug discovery & development

225 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering Precision Biocontrols Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODYTM technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from …

257 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Antibody Services from Discovery to Clinical Supply Since 2001, Fusion Antibodies has been dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry. We offer a complete range of antibody-related services in Discovery, Engineering and Supply and have guided hundreds of projects through critical preclinical stages. Fifteen of our client’s projects have advanced to clinical stages, some as far as Phase II. We deliver a superior service for the development of antibodies by beginning each project with the end in mind. Our scientists are experts in early stage discovery of …

137 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Oral Delivery . Genetic Breakthroughs We are a preclinical-stage biotech company focused on developing revolutionary therapies to address Inflammatory Bowel Diseases. Harnessing the unique capabilities of our Genetic Medicines Oral Delivery platform we aim to overcome major limitations of current treatments and unlock the groundbreaking potential of Genetic Medicines in IBDs, driving transformative change in a field with critical medical needs.

92 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995. We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website. The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the …

106 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

At FairJourney Bio, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 19 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether you're in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs. Join us in revolutionizing therapeutic discovery and making lasting impacts on global healthcare. Monoclonal antibodies, Antibody humanization, Antibody production, Antibody affinity maturation, Phage display libraries, Mammalian Display, Naïve Libraries, VHH …

193 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR). Monoclonal Antibody , Infectious Disease, Cell line Engineering, Inhalation therapy

147 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

418 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

We supply the world with active pharmaceutical ingredients Farmabios is a leading global manufacturer of highly potent active pharmaceutical ingredients. With decades of steroid and complex chemistry expertise, and newly opened research and development projects in various fields, Farmabios provides bespoke products and solutions, understanding customer needs. Steroids, Chemistry, Active Pharmaceutical Ingredients, Hormones, Drug Substances, Healthcare, Pharmaceuticals, and Bespoke products

64 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Your partner in immunotechnologies since 1980! Our commitment makes the difference! Expert in immunotechnology, BIOTEM is a contract Research Organisation which complies with ISO 9001:2008 quality standards. Since its establishment in 1980, the company has been the privileged partner of prestigious industrial and academic laboratories for their R&D, diagnostic and therapeutic projects. Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project and is pledged to achieve the results outlined in the contract. BIOTEM advantages: - Results guaranteed - An unparalleled traceability throughout your project - Optimal quality of your product …

87 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Antibody Magic Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need with an internal pipeline focusing on pain. The company uses Abiprot®, a proprietary, next-generation antibody platform to identify accessible epitopes for antibody development. biotech, antibody, drug development, and pain

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Oak Hill Bio's mission is to develop life-changing medicines for patients suffering from rare diseases Oak Hill Bio is a clinical-stage biotech company committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Revolutionizing the storage and delivery of vaccines and therapeutics. We are a biotechnology company revolutionizing vaccines and biologics by removing all cold storage requirements and expediting manufacturing.

97 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are …

276 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large …

257 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Bioinnovation at your service. Biomedal S.L is a biotechnology company whose mission is to develop and commercialize new technologies, services and products for research, bioindustry and diagnostics. The company develops its activities in two areas: Biomedal Life Sciences and Biomedal Diagnostics. Biomedal Life Science is devoted to the development and commercialization of products and services for life sciences research, and technology for industrial bioprocesses. Its own technology allowed the improvement of recombinant protein production.Biomedal Life Science also functions as a CRO (Contract Research Organization) and provides services and support to pharmaceutical or biotechnology companies. Biomedal Diagnostics offers a large variety …

164 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

making a difference Greiner Bio-One: Innovative solutions for your hospitals, laboratories and research facilities We specialize in the development, production and distribution of high-quality plastic products for laboratories worldwide. As a reliable technology partner, we support hospitals, research institutions, laboratories as well as the diagnostic, pharmaceutical and biotechnology industries with customized solutions. Our focus: ☑ Preanalytics: We are setting new standards in safety and efficiency with innovative collection systems for blood, urine and saliva sampling. Our customized digital solutions (Greiner eHealth Technologies) optimize processes and increase patient safety in laboratories and medical practices. ☑ BioScience: We offer highly specialized products …

481 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases. Zymeworks is a global biotechnology company developing and managing a portfolio of differentiated biotherapeutics to improve the standard of care for patients with difficult-to-treat cancers and autoimmune diseases. Leveraging our proprietary antibody engineering platforms, we are advancing a diverse pipeline of multispecific antibodies and antibody-drug conjugates, alongside partnered programs including Ziihera® (zanidatamab-hrii). Our integrated R&D engine and strategic partnerships enable the novel design of next-generation antibody therapeutics addressing significant unmet medical need. antibody therapeutics, bispecific antibodies, ADC, Breast Cancer, Gastric Cancer, protein engineering, Biliary Tract Cancer, autoimmune diseases, …

116 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology